Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Hurst

Showing results (41-50 of 341) with videos related to

Pageof 35
Sort By:
BMJ (Clinical Research Ed.)|April 6, 2011
Frequent exacerbations in chronic obstructive pulmonary diseaseChristina George, Will Zermansky, John R Hurst
The Lancet. Respiratory Medicine|July 20, 2015
Lung disease in primary antibody deficiencyNisha Verma, Bodo Grimbacher, John R Hurst
Frontiers in Immunology|July 26, 2021
Editorial: Interstitial Lung Disease in Primary ImmunodeficienciesBørre Fevang, Klaus Warnatz, John R Hurst
The Lancet. Respiratory Medicine|August 31, 2017
Susceptibility to exacerbation in COPDJohn R Hurst, Antonio Anzueto, Jørgen Vestbo
European Respiratory Review : an Official Journal of the European Respiratory Society|October 5, 2018
Cardiovascular disease and COPD: dangerous liaisons?Klaus F Rabe, John R Hurst, Samy Suissa
Clinical Medicine (London, England)|October 24, 2019
The National COPD Audit - what you need to knowJohn R Hurst, Viktoria McMillan, C Michael Roberts
Archivos De Bronconeumologia|March 7, 2022
The Impact of Re-Admissions in COPDJaber S Alqahtani, Swapna Mandal, John R Hurst
Journal of Hepatology|April 2, 2016
Update on alpha-1 antitrypsin deficiency: New therapiesDavid A Lomas, John R Hurst, Bibek Gooptu
American Journal of Respiratory and Critical Care Medicine|February 15, 2024
Funding Population-based Cohorts: Still Relevant for Respiratory Epidemiology in the Era of Big DataWilliam Checkley, John R Hurst, Robert A Wise
Chest|October 16, 2007
Mechanism of statin-associated mortality reduction in COPDJohn R Hurst, Gerry Hagan, Jadwiga A Wedzicha
Pageof 35

Showing results (41-50 of 341) with videos related to

Sort By:
Pageof 35
BMJ (Clinical Research Ed.)|April 6, 2011
Frequent exacerbations in chronic obstructive pulmonary diseaseChristina George, Will Zermansky, John R Hurst
The Lancet. Respiratory Medicine|July 20, 2015
Lung disease in primary antibody deficiencyNisha Verma, Bodo Grimbacher, John R Hurst
Frontiers in Immunology|July 26, 2021
Editorial: Interstitial Lung Disease in Primary ImmunodeficienciesBørre Fevang, Klaus Warnatz, John R Hurst
The Lancet. Respiratory Medicine|August 31, 2017
Susceptibility to exacerbation in COPDJohn R Hurst, Antonio Anzueto, Jørgen Vestbo
European Respiratory Review : an Official Journal of the European Respiratory Society|October 5, 2018
Cardiovascular disease and COPD: dangerous liaisons?Klaus F Rabe, John R Hurst, Samy Suissa
Clinical Medicine (London, England)|October 24, 2019
The National COPD Audit - what you need to knowJohn R Hurst, Viktoria McMillan, C Michael Roberts
Archivos De Bronconeumologia|March 7, 2022
The Impact of Re-Admissions in COPDJaber S Alqahtani, Swapna Mandal, John R Hurst
Journal of Hepatology|April 2, 2016
Update on alpha-1 antitrypsin deficiency: New therapiesDavid A Lomas, John R Hurst, Bibek Gooptu
American Journal of Respiratory and Critical Care Medicine|February 15, 2024
Funding Population-based Cohorts: Still Relevant for Respiratory Epidemiology in the Era of Big DataWilliam Checkley, John R Hurst, Robert A Wise
Chest|October 16, 2007
Mechanism of statin-associated mortality reduction in COPDJohn R Hurst, Gerry Hagan, Jadwiga A Wedzicha
Pageof 35